Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
-
Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
Pre- Congress Workshops 28th October 2019
-
-
Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
-
Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
-
Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
-
Research, development and strategic partnering for the global vaccine industry
29-31 October 2019 | Barcelona
2019 Scientific Advisory Board
The agenda is being shaped by an industry advisory board, with members including:
Professor Albert Osterhaus
Director, Research Center for Emerging Infections and Zoonoses (RIZ)
University of Veterinary Medicine Hannover
Dr Jeffrey Almond
Former Vice President Discovery Research and Development, Sanofi and Visiting Professor
University of Oxford - Oxford Vaccine Group
Dr Annaliesa Anderson
VP Bacterial Vaccines
Pfizer
Dr Jan Poolman
Head Bacterial Vaccine Discovery and Early Development
Janssen
Dr Gregory A. Poland
Director of Mayo Vaccine Research Group
Mayo Clinic and Foundation
Dr Antu Dey
Senior Director, Research & Development
International AIDS Vaccine Initiative
Dr Konrad Stradler
Head of R&D Vaccines
Boehringer Ingelheim
Dr Roy Baynes
Senior Vice President Global Clinical Development and Chief Medical Officer
MSD
Dr Nathalie Garçon
CEO & CSO
BIOASTER
Dr Cyril Gay
Senior National Program Leader, Office of National Programs
USDA
Dr Rino Rappuoli
Chief Scientist
GSK Vaccines
Dr Mahesh Kumar
Vice President, Global Biologics Research
Zoetis
Dr Bernard Vallat
Honorary Director General
Office International Des Epizooties
Dr Ralf Clemens
SVP
GRID Rio
Dr Jerald Sadoff
Senior Advisor
Janssen Infectious Diseases and Vaccines
Dr Lorne A. Babiuk
Former Vice-President
University of Alberta
Prof Roman Prymula
Professor Preventive Medicine
Charles University in Prague
Prof Hanna Nohynek
Deputy Director
Finish Public Health
Prof Fred Zepp
Medical Director and Chairman of the Department of Paediatrics
University Medicine Mainz
Dr Joris Vandeputte
President
IABS (International Alliance for Biological Standardization)
Prof Hanneke Schuitemaker
Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area
Janssen Vaccines
Dr Miles Carroll
Deputy Director
Public Health England
Dr Christiane Gerke
Head of Vaccine Programs
Institut Pasteur
600+
Attendees
300+
Companies
80%
Decision makers
175+
Speakers
8
Conference tracks
3
Co-located conferences
New vaccine & immuno-oncology profiling technology is
changing the whole industry
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.
By bringing eight tracks together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.
Take just three days out of the office to meet over 500+ potential customers who need to find solutions to their challenges.
Build three days of totally tailored content and attendees.
CO-LOCATED WITH
CONFERENCE TRACKS INCLUDE
Welcome to World Vaccine Congress Europe
"A very interesting and well organised conference, with plenty of opportunity for networking"
Chief Scientific Officer, Prokarium Ltd
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the World Vaccine Congress, World Veterinary Vaccine Congress and Immune Profiling World Congress, we have content, networking and potential partners for you.
Download the prospectus to find out exactly what's in store for this year's event.
Sign Up for Event Updates
Organiser
